Mankind Pharma Limited has completed the transaction to acquire 100% stake in Bharat Serums and Vaccines Limited (BSV), for a purchase consideration of INR 13,768 Crores. This strategic move marks a significant leap for Mankind Pharma, positioning it as a market leader in the Indian
Expands high entry barrier portfolio; Leadership in Women’s Health (#1 in Gynae IPM[i]) High entry barrier portfolio with specialty R&D tech platforms across - Recombinants, Niche Biologics, Novel Delivery and Immunoglobulins Only innovator in the world to develop patented recombinant Anti-D Brands across Women’s Health
